Total raised
$1.1M
Last: Seed 2022-05
Stage
Seed
Founded
2021
Headcount
12
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences
About
Infiniplex's mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at an accessible and affordable cost. The company's goal is to identify common and rare cancer types through a standard, inexpensive blood test that could be carried out as part of routine checkups, leveraging existing laboratory equipment and know-how. Infiniplex aims to include tumor genomic testing as part of people's standard blood test checkups.
Funding history · 1 round · $1.1M total
2022-05
Seed
$1.1M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsMoleculesGenesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesMedical Devices IndustryHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
screeningbiomarkerscancer-diagnosticsmachine-learningmonitoringhealthcarebiotechnologyoncologydiagnosticscancermedical-technologiesgeneticsbioinformatics